NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine-Reference-Cited by-同舟云学术

NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine

Published:2022-04 Issue: Volume:43 Page:100436
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Khaeso Kanyarat,Komvilaisak Patcharee,Chainansamit Su-on^ORCID,Nakkam Nontaya^ORCID,Suwannaying Kunanya,Kuwatjanakul Pitchayanan,Hikino Keiko^ORCID,Dornsena Areerat,Kanjanawart Sirimas,Laoaroon Napat,Vannaprasaht Suda,Taketani Takeshi,Tassaneeyakul Wichittra^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference49 articles.

1. The clinical pharmacology of 6-mercaptopurine;Lennard;Eur J Clin Pharmacol,1992

2. Three faces of mercaptopurine cytotoxicity in vitro: methylation, nucleotide homeostasis, and deoxythioguanosine in DNA;Coulthard;Drug Metab Dispos,2018

3. Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations;Lennard;Clin Pharmacol Ther,1987

4. Thiopurine S-methyltransferase genetic polymorphism in the Thai population;Srimartpirom;Br J Clin Pharmacol,2004

5. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia;McLeod;Leukemia,2000

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detailed resume of S-methyltransferases: Categories, structures, biological functions and research advancements in related pathophysiology and pharmacotherapy;Biochemical Pharmacology;2024-08

2. Association of <i>NUDT15</i> gene polymorphism with adverse reaction, treatment efficacy, and dose of 6-mercaptopurine in patients with acute lymphoblastic leukemia: a systematic review and meta-analysis;Haematologica;2023-10-05

3. Optimizing thiopurine therapy in children with acute lymphoblastic leukemia: A promising “MINT” sequencing strategy and therapeutic “DNA-TG” monitoring;Frontiers in Pharmacology;2022-09-27